CR/iStock via Getty Images An increasing number of states are considering adding coverage for GLP-1 weight loss medications for their Medicaid enrollees. Eli Lilly's ( NYSE: LLY ) Zepbound (tirzepatide) and Novo Nordisk's ( NVO ) Wegovy (semaglutide) are the two most popular -- and expensive -- GLP-1 meds used for this.
Back to Health Page
